Taravat Ghafourian

Dr. Taravat Ghafourian

Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, Florida, USA
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2003 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Ali NokhodchiAli Nokhodchi
Ali Nokhodchi
JSJ. Shokri
J. Shokri
ADA. Dashbolaghi
A. Dashbolaghi
DHD. Hassan-Zadeh
D. Hassan-Zadeh
Taravat GhafourianTaravat Ghafourian
Taravat Ghafourian
MBM. Barzegar-Jalali
M. Barzegar-Jalali

1 October 2001 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
JSJ. Shokri
J. Shokri
Ali NokhodchiAli Nokhodchi
Ali Nokhodchi
ADA. Dashbolaghi
A. Dashbolaghi
DHD. Hassan-Zadeh
D. Hassan-Zadeh
Taravat GhafourianTaravat Ghafourian
Taravat Ghafourian
MJM. Barzegar Jalali
M. Barzegar Jalali

1 September 2004 in Journal of Controlled Release
Verified
Journal Article
Closed access
Taravat GhafourianTaravat Ghafourian
Taravat Ghafourian
PZParinaz Zandasrar
Parinaz Zandasrar
HHHamed Hamishekar
Hamed Hamishekar
Ali NokhodchiAli Nokhodchi
Ali Nokhodchi

22 April 2009 in Journal of Chemical & Engineering Data
Verified
Journal Article
Closed access
Abolghasem JouybanAbolghasem Jouyban
Abolghasem Jouyban
JSJavad Shokri
Javad Shokri
MBMohammad Barzegar-Jalali
Mohammad Barzegar-Jalali
DHDavoud Hassanzadeh
Davoud Hassanzadeh
WAWilliam E. Acree
William E. Acree
Ali NokhodchiAli Nokhodchi
Ali Nokhodchi

1 April 2007 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Ali NokhodchiAli Nokhodchi
Ali Nokhodchi
KSK. Sharabiani
K. Sharabiani
MRMohammad-Reza Rashidi
Mohammad-Reza Rashidi
Taravat GhafourianTaravat Ghafourian
Taravat Ghafourian

4 November 2003 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
MAMichael H. Abraham
Michael H. Abraham
MHMostafa Hassanisadi
Mostafa Hassanisadi
MJMehdi Jalali-Heravi
Mehdi Jalali-Heravi
Taravat GhafourianTaravat Ghafourian
Taravat Ghafourian
WCWilliam. S. Cain
William. S. Cain
JCJ. Enrique Cometto-Muñiz
J. Enrique Cometto-Muñiz
Draize rabbit eye test scores, as modified maximum average score (MMAS), for 68 pure bulk liquids were adjusted by the liquid-saturated vapor pressure P°. These 68 adjusted scores, as log (MMAS/P°), were shown to be completely equivalent to eye irritation thresholds (EIT), expressed as log (1/EIT), for 23 compounds in humans. Thus, for the first time the Draize eye test in rabbits for pure bulk liquids is shown to be perfectly compatible with eye irritation thresholds in humans. The total data set for 91 compounds was analyzed by the general solvation equation of Abraham. Values of log (MMAS/P°) or log (1/EIT) could be fitted to a five-parameter equation with R2 = 0.936, SD = 0.433, AD = 0.000, and AAD = 0.340 over a range of 9.6 log units. When divided into a training set of 45 compounds, the corresponding equation could be used to predict the remaining 46 compounds in a test set with AD = −0.037 and AAD = 0.345 log units. Thus, the 91-compound equation can now be used to predict further EIT values to around 0.4 log units. It is suggested that the mechanism of action in the Draize test and in the human EIT involves passive transfer of the compound to a biophase that is quite polar, is a strong hydrogen bond base, a moderate hydrogen bond acid, and quite hydrophobic. The biophase does not resemble water or plasma, but resembles an organic solvent such as N-methylformamide.